To Compare Mineral Trioxide Aggregate, Platelet-rich Fibrin, and Calcium Hydroxide in Teeth with Irreversible Pulpitis: A Clinical Study

AIM: Numerous pulp-capping agents such as mineral trioxide aggregate (MTA), calcium hydroxide (Ca(OH)(2)), platelet-rich fibrin (PRF), and biodentine have been suggested. This clinical study was conducted to compare MTA, PRF, and Ca(OH)(2) in teeth with irreversible pulpitis. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Revati, Singh, Rohit, Kavita, Kumari, Kommula, Apoorva, Kulkarni, Ganesh, Jois, Harshvardhan Shridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595498/
https://www.ncbi.nlm.nih.gov/pubmed/33149501
http://dx.doi.org/10.4103/jpbs.JPBS_130_20
Descripción
Sumario:AIM: Numerous pulp-capping agents such as mineral trioxide aggregate (MTA), calcium hydroxide (Ca(OH)(2)), platelet-rich fibrin (PRF), and biodentine have been suggested. This clinical study was conducted to compare MTA, PRF, and Ca(OH)(2) in teeth with irreversible pulpitis. MATERIALS AND METHODS: The 60 mandibular molar teeth with irreversible pulpitis were used in this study, which were restored with Ca(OH)(2), MTA, and PRF. Assessments of the treatment were carried out at 6 months and 1 year by clinical examination and also radiographically. RESULTS: A nonsignificant difference was observed in pain intensity recorded at numerical rating scale at baseline, 24h, 1 week, 1 month, 3 months, 6 months, and 1 year. A nonsignificant (P > 0.05) difference was reported in clinical and radiographic success rate recorded at 6 months and 1 year in all groups. CONCLUSION: Pulp-capping agents such as Ca(OH)(2), MTA, and PRF yielded similar success rate when used in teeth with irreversible pulpitis.

Ejemplares similares